News

Hilleman Laboratories is committed to developing high impact, affordable vaccines for people in developing countries in an innovative and sustainable manner.

Hilleman Labs announces publication of original research on Heat Stable Rotavirus Vaccines

Date: 11/09/2018

Hilleman Labs announces publication of original research on Heat Stable Rotavirus Vaccines

Hilleman Laboratories today announced the publication of original research as well as expert commentary on development of Heat Stable Rotavirus Vaccine (HSRV).
View All